Patents by Inventor Atanu Roy

Atanu Roy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TERMINALLY MODIFIED RNA
    Publication number: 20220395562
    Abstract: The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules via optimization of their terminal architecture.
    Type: Application
    Filed: December 18, 2020
    Publication date: December 15, 2022
    Inventors: Tirtha CHAKRABORTY, Stephane BANCEL, Stephen G. HOGE, Atanu ROY, Antonin DE FOUGEROLLES, Noubar B. AFEYAN
  • MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS
    Publication number: 20220273555
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
    Type: Application
    Filed: April 28, 2020
    Publication date: September 1, 2022
    Inventors: Stephane BANCEL, Tirtha CHAKRABORTY, Antonin DE FOUGEROLLES, Sayda M. ELBASHIR, Matthias JOHN, Atanu ROY, Susan WHORISKEY, Kristy M. WOOD, Paul HATALA, Jason P. SCHRUM, Kenechi EJEBE, Jeff Lynn ELLSWORTH, Justin GUILD
  • MACHINE-LEARNING SYSTEM AND METHOD FOR IDENTIFYING SAME PERSON IN GENEALOGICAL DATABASES
    Publication number: 20210365803
    Abstract: Systems and methods for determining whether two tree persons in a genealogical database correspond to the same real-life individual. Embodiments include identifying two tree persons in a genealogical database and extracting a plurality of features from both tree persons to generate two vectors. Embodiments also include calculating a plurality of metrics between the two vectors to generate a metric function. Embodiments further include generating feature weights using a recursive process based on training data input by external users, and generating a score by calculating a weighted sum of the metric function being weighted by the feature weights. The generated score may then be compared to a threshold value.
    Type: Application
    Filed: August 3, 2021
    Publication date: November 25, 2021
    Applicant: Ancestry.com Operations Inc.
    Inventors: Atanu Roy, Jianlong Qi, Peng Jiang, Aaron Ling, Rey Furner, Lei Wu, Eugene Greenwood, Ian Stiles
  • MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF
    Publication number: 20210308283
    Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: September 25, 2020
    Publication date: October 7, 2021
    Inventors: Antonin DE FOUGEROLLES, Atanu ROY
  • MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
    Publication number: 20210299278
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
    Type: Application
    Filed: September 14, 2020
    Publication date: September 30, 2021
    Inventors: Stephane BANCEL, Tirtha CHAKRABORTY, Antonin DE FOUGEROLLES, Sayda M. ELBASHIR, Matthias JOHN, Atanu ROY, Susan WHORISKEY, Kristy M. WOOD, Paul HATALA, Jason P. SCHRUM, Kenechi EJEBE, Jeff Lynn ELLSWORTH, Justin GUILD
  • Machine-learning system and method for identifying same person in genealogical databases
    Patent number: 11113609
    Abstract: Systems and methods for determining whether two tree persons in a genealogical database correspond to the same real-life individual. Embodiments include identifying two tree persons in a genealogical database and extracting a plurality of features from both tree persons to generate two vectors. Embodiments also include calculating a plurality of metrics between the two vectors to generate a metric function. Embodiments further include generating feature weights using a recursive process based on training data input by external users, and generating a score by calculating a weighted sum of the metric function being weighted by the feature weights. The generated score may then be compared to a threshold value.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: September 7, 2021
    Assignee: ANCESTRY.COM OPERATIONS INC.
    Inventors: Atanu Roy, Jianlong Qi, Peng Jiang, Aaron Ling, Rey Furner, Lei Wu, Eugene Greenwood, Ian Stiles
  • MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
    Publication number: 20210115101
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
    Type: Application
    Filed: October 28, 2019
    Publication date: April 22, 2021
    Inventors: Stephane BANCEL, Tirtha CHAKRABORTY, Antonin DE FOUGEROLLES, Sayda M. ELBASHIR, Matthias JOHN, Atanu ROY, Susan WHORISKEY, Kristy M. WOOD, Paul HATALA, Jason P. SCHRUM, Kenechi EJEBE, Jeff Lynn ELLSWORTH, Justin GUILD
  • Terminally Modified RNA
    Patent number: 10925935
    Abstract: The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules via optimization of their terminal architecture.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: February 23, 2021
    Assignee: ModernaTX, Inc.
    Inventors: Tirtha Chakraborty, Stephane Bancel, Stephen G. Hoge, Atanu Roy, Antonin De Fougerolles, Noubar B. Afeyan
  • Modified Polynucleotides for the production of biologics and proteins associated with human disease
    Patent number: 10772975
    Abstract: The invention relates to a pharmaceutical composition including a plurality of lipid nanoparticles having a mean particle size of between 80 nm and 160 nm and containing an mRNA encoding a polypeptide. The lipid nanoparticles include a cationic lipid, a neutral lipid, a cholesterol, and a PEG lipid. The mRNA contains a 5?-cap, 5?-UTR, a 3?-UTR, and a poly-A region with at least 100 nucleotides.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: September 15, 2020
    Assignee: ModernaTX, Inc.
    Inventors: Stephane Bancel, Tirtha Chakraborty, Antonin De Fougerolles, Sayda M. Elbashir, Matthias John, Atanu Roy, Susan Whoriskey, Kristy M. Wood, Paul Hatala, Jason P. Schrum, Kenechi Ejebe, Jeff Lynn Ellsworth, Justin Guild
  • TERMINALLY MODIFIED RNA
    Publication number: 20190290742
    Abstract: The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules via optimization of their terminal architecture.
    Type: Application
    Filed: October 5, 2018
    Publication date: September 26, 2019
    Applicant: ModernaTX, Inc.
    Inventors: Tirtha CHAKRABORTY, Stephane BANCEL, Stephen G. HOGE, Atanu ROY, Antonin DE FOUGEROLLES, Noubar B. AFEYAN
  • ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
    Publication number: 20190255194
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Application
    Filed: March 1, 2019
    Publication date: August 22, 2019
    Inventors: Atanu ROY, Christopher R. CONLEE, Antonin DE FOUGEROLLES, Andrew W. FRALEY, Gabor BUTORA, Matthew STANTON
  • Polynucleotide molecules and uses thereof
    Patent number: 10385088
    Abstract: The present disclosure provides alternative sugar moieties and polynucleotides comprising such sugar moieties, and methods of use thereof.
    Type: Grant
    Filed: October 2, 2014
    Date of Patent: August 20, 2019
    Assignee: ModernaTX, Inc.
    Inventors: Andrew W. Fraley, Atanu Roy, Matthew Stanton
  • MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
    Publication number: 20190240351
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
    Type: Application
    Filed: October 20, 2017
    Publication date: August 8, 2019
    Inventors: Stephane BANCEL, Tirtha CHAKRABORTY, Antonin DE FOUGEROLLES, Sayda M. ELBASHIR, Jeff Lynn ELLSWORTH, Kenechi EJEBE, Justin GUILD, Matthias JOHN, Paul HATALA, Atanu ROY, Jason P. SCHRUM, Susan WHORISKEY, Kristy M. WOOD
  • Alternative nucleic acid molecules and uses thereof
    Patent number: 10286086
    Abstract: The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: May 14, 2019
    Assignee: ModernaTX, Inc.
    Inventors: Atanu Roy, Christopher R. Conlee, Antonin De Fougerolles, Andrew W. Fraley, Gabor Butora, Matthew Stanton
  • Terminally modified RNA
    Patent number: 10155029
    Abstract: The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules via optimization of their terminal architecture.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: December 18, 2018
    Assignee: ModernaTX, Inc.
    Inventors: Tirtha Chakraborty, Stephane Bancel, Stephen G. Hoge, Atanu Roy, Antonin De Fougerolles, Noubar B. Afeyan
  • MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
    Publication number: 20180311381
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
    Type: Application
    Filed: October 23, 2017
    Publication date: November 1, 2018
    Inventors: Stephane BANCEL, Tirtha CHAKRABORTY, Antonin DE FOUGEROLLES, Sayda M. ELBASHIR, Matthias JOHN, Atanu ROY, Susan WHORISKEY, Kristy M. WOOD, Paul HATALA, Jason P. SCHRUM, Kenechi EJEBE, Jeff Lynn ELLSWORTH, Justin GUILD
  • MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
    Publication number: 20180170990
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
    Type: Application
    Filed: July 27, 2017
    Publication date: June 21, 2018
    Inventors: Stephane BANCEL, Tirtha CHAKRABORTY, Antonin DE FOUGEROLLES, Sayda M. ELBASHIR, Matthias JOHN, Atanu ROY, Susan WHORISKEY, Paul HATALA, Jason P. SCHRUM, Kenechi EJEBE, Jeff Lynn ELLSWORTH, Justin GUILD, Ron WEISS, Kristy M. WOOD
  • MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
    Publication number: 20180086807
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
    Type: Application
    Filed: February 23, 2017
    Publication date: March 29, 2018
    Inventors: Stephane BANCEL, Tirtha CHAKRABORTY, Antonin DE FOUGEROLLES, Sayda M. ELBASHIR, Matthias JOHN, Atanu ROY, Susan WHORISKEY, Kristy M. WOOD, Paul HATALA, Jason P. SCHRUM, Kenechi EJEBE, Jeff Lynn ELLSWORTH, Justin GUILD
  • Platform for patient monitoring
    Patent number: 9872087
    Abstract: A system for storing data collected by a body-worn sensor includes a central processing unit (CPU) that is configured to control operation of a gateway device; and one or more computer readable data storage media storing software instructions that, when executed by the CPU, cause the gateway device to: receive a MAC address of a new sensor and a protocol version associated with the new sensor from a server; attempt to contact the new sensor using the protocol version and the MAC address; when a response is received, send the response to the server for validation; when the response is validated by the server, establish communications with the new sensor; and forward data from the new sensor to a second server.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: January 16, 2018
    Assignee: WELCH ALLYN, INC.
    Inventors: James J. DelloStritto, Atanu Roy Chowdhury, Harrish Mugundhan, Adam P. Vallee, Laleh Rabieirad
  • TERMINALLY MODIFIED RNA
    Publication number: 20180000910
    Abstract: The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules via optimization of their terminal architecture.
    Type: Application
    Filed: February 10, 2017
    Publication date: January 4, 2018
    Inventors: Tirtha CHAKRABORTY, Stephane BANCEL, Stephen G. HOGE, Atanu ROY, Antonin de FOUGEROLLES, Noubar B. AFEYAN